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To the Editor:
I read with great interest the report
by Sharma and colleagues1 about their
experience with aortic valve (AV)
repair and congratulate them on their
honest presentation of the long-term
data. I believe, however, that the
interpretation of some aspects needs
additional comments and questions.
The authors stated that survival after
AV repair in their population was
excellent and, with 91%, 80%, and
58% survival at 5, 10, and 15 years,
respectively, was indistinguishable
from the healthy population. Such a
survival of the healthy population
with a median age of 54 years seems
to be rather low, and this impression
could be intensified when looking at
the US Life Tables,2 which revealed
corresponding survival rates of 96%,368 The Journal of Thoracic and C90%, and 83% for a 54-year-old
population containing 76% men.
The authors found (not unexpectedly,
because this aspect has already been
revealed after AV replacement3) that
myocardial impairment (MI) was a
significant predictor of mortality.
They correctly noted that this is barely
avoidable, because the late presenta-
tion of symptoms in some patients
with aortic insufficiency does not
lead to referral for surgery until the
development of MI. They suggested,
however, earlier surgery for patients
with suitable repair anatomy. In this
context, 2 questions arise: how
reliable is the assessment of AV repair
suitability; and are patients with MI
proper candidates for AV repair? I
believe AV replacement should be
preferred for patients with consider-
able MI because such patients need a
fast and safe surgery without the risk
of residual or recurrent insufficiency,
let alone any intraoperative revisions.
The remaining aortic insufficiency,
which can never be ruled out after
repair, can even be considered as a
potential factor that can worsen long-
term survival in this special subgroup.
However, the authors did not provide
the rate of postoperative aortic insuffi-
ciency—neither in the entire nor in
this special cohort. Thus, I am
wondering whether the rate of reoper-
ation alone would be adequate enough
for assessment of clinical and, espe-
cially, functional results. Furthermore,
the number of patients operated at
Mayo Clinic, with an average of about
12 annually, does not indicate that a
considerable share of aortic valve
pathologic entities could be scheduled
for the repair. By coincidence, we
submitted an abstract for the same
American Association for Thoracic
Surgery meeting that included 137
repairs performed during a 1-year
period, but it was not well received
by the reviewers.
It seems that AV repairs are still
limited to single centers or, even, sur-
geons; hence, we can hardly speak
about the ‘‘expanding relevance ofardiovascular Surgery c July 2014AV repair.’’ The repair rate, as pre-
sented in our abstract, was 40% for
all AV surgery patients younger than
70 years or, after excluding patients
with contraindications (eg, MI), even
greater. Even if the suitability of repair
could be assessed with a probability of
about 80%, the final decision for AV
repair was always performed during
surgery. Thus, I am convinced that
AV repair is a valuable option; how-
ever, the repair candidates must fulfill
the same indication criteria as for AV
replacement,3 because the need for
replacement can never be ruled out.
Paul P. Urbanski, MD, PhD
Cardiovascular Clinic Bad Neustadt
Bad Neustadt, Germany
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THE BEST ALTERNATIVE IN
SURGERY FOR ATRIAL
FIBRILLATION
To the Editor:
We read with particular attention
the article by Stulak and colleagues.1
After close scrutiny of this report
one cannot escape the conclusion
that standard cut-and-sew Cox maze
III procedure, as first described by
Cox and associates,2 remains the cri-
terion standard choice for the surgical
treatment of any type of atrial fibrilla-
tion (AF). Of special interest is the en-
tity of mitral valve (MV) disease with
concomitant long-standing persistent
